

The Vox Markets Podcast
Vox Markets Podcast
Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.
Episodes
Mentioned books

Dec 11, 2024 • 1h 10min
2003: Small-Cap Investing with Paul Hill & Paul Scott
Watch on YouTube
Tell us what you think of Vox Markets on Good Money Guide: https://goodmoneyguide.com/review/vox-markets/
In this week’s smallcap investing show, uber smart UK investor Paul Scott & I discussed our latest thoughts on the following:
00:00 Investor sentiment, recruiters & recent buys/sells.
07:50 Equals
13:55 James Latham
17:35 Warpaint
21:45 Springfield and housebuilders
25:25 Premier Miton
29:55 Victrex
36:45 Boohoo
38:00 SSP Group
39:55 Card Factory
42:40 Zigup
46:15 IXICO
50:20 Onthebeach
54:45 De La Rue
57:35 Water Intelligence
59:30 Made Tech
62:25 Plexus
64:30 Avacta
#EQLS #LTHM #W7L #SPR #PMI #VCT #BOO #SSPG #CARD #ZIG #IXI #OTB #DLAR #WATR #MTEC #POS #AVCT

Dec 11, 2024 • 10min
2002: Q&A with Georgina Energy CEO, Tony Hamilton
Watch on YouTube
Georgina Energy #GEX has announced significant progress regarding the permitting for the Mount Winter helium and hydrogen project in Australia. Chief executive Tony Hamilton joins to tell us more, and about next steps.

Dec 11, 2024 • 13min
2001: Q&A with Renalytix Executive Chairman, Julian Baines
Watch on YouTubeRenalytix #RENX, specialises in AI-powered diagnostics for kidney disease. Executive Chairman Julian Baines, in an interview with Vox Markets, highlighted the company's FDA-approved test, KidneyIntelX, which predicts end-stage renal disease risk in diabetic patients, improving outcomes and reducing healthcare costs.

Dec 10, 2024 • 8min
2000: Q&A with Gunsynd Executive Chairman, Hamish Harris
Watch on YouTubeGunsynd #GUN has rounded off a transformational year with news of extensive additional mineralisation on the Bear-Twit project in Canada. We're joined by executive chairman Hamish Harris to talk about that, as well as uranium and the way the company's assets are positioned locally and strategically. Will there be more deals next year? Never say never, says Hamish

Dec 10, 2024 • 8min
1999: Q&A with hVIVO’s Mo Khan
Watch on YouTubehVIVO #HVO CEO, Yamin 'Mo' Khan announced an £11.5 million contract with an existing top-tier global pharmaceutical client to test an RSV antiviral candidate using hVIVO's Human Challenge Study Model. The Phase 2a trial is set to begin in the second half of 2025 at hVIVO's Canary Wharf quarantine facilities.

Dec 4, 2024 • 47min
1998: IXICO Full Year Results & Growth Strategy Webinar
Watch on YouTubeCatch the highlights from IXICO's #IXI live presentation, where CEO Bram Goorden and CFO Grant Nash share insights into the company's Full Year Results and outline their ambitious expansion and growth strategy. Recorded on December 4th, 2024, this session provides valuable updates for shareholders and those interested in IXICO's role in advancing neuroscience through innovative medical imaging analysis. 00:00 - Introduction01:10 - Presentation 33:40 - Q&A

Dec 4, 2024 • 24min
1997: Q&A with IXICO CEO, Bram Goorden and CFO, Grant Nash
Watch on YouTube
In this upbeat interview following today’s positive Sept FY24 results, CEO Bram Goorden and CFO Grant Nash of
IXICO - an AI powered medical imaging analytics firm - takes me through:
00:00 What IXICO does, its key USPs & growth opportunity.
06:05 Financial highlights, operating leverage and breakeven sales.
11:50 Expansion strategy and new product development.
18:55 FY25 outlook and closing remarks.
IXICO will provide a live presentation to all existing and potential shareholders relating to their Full Year Results and IXICO's expansion and growth strategy via Vox Markets this afternoon.
Register here > > https://streamyard.com/watch/tuGDjEfcp5K4

Dec 2, 2024 • 1h 12min
1996: The Exchange with Laurence Hulse of Onward Opportunities
Watch on YouTubeIn this fascinating interview, I was delighted again to speak to accomplished fund manager Laurence Hulse of onward Opportunities, including:00:00 His investment approach & smallcap outlook for 202503:50 Windward08:45 Angling Direct12:20 Springfield Props16:25 Mpac22:05 Transense Technologies27:25 Synectics,33:25 Mission Group37:40 Vianet41:00 Likewise44:40 Alumasc48:35 Michelmersh51:50 Audioboom56:30 Smiths News1:00:50 React1:03:15 Northcoders1:07:20 B90 Holdings1:10:45 Favourite stock for 2025Plus, if anyone or any company would like to sponsor this fund manager series (re naming rights), then please feel free to contact me here or via my email paulhill@pmhcapital.com.#ONWD #TRT #MPAC #WNWD #SPR #SNWS #ANG #VNET #SNX #TMG #LIKE #ALU #MBH #BOOM #REAT #CODE #B90

Dec 2, 2024 • 8min
1995: Q&A with Supreme CEO, Sandy Chadha
Watch on YouTube
In this interview, CEO Sandy Chadha of Supreme takes me through the strategic logic underpinning today's synergistic £10.2m acquisition of Typhoo Tea. A beloved UK heritage brand that has been enjoyed by consumers for 120+ years and remains as one of the country’s top 5 tea names.

Nov 30, 2024 • 1h 5min
1994: Small-Cap Investing with Paul Hill & Paul Scott
Watch on YouTubeTell us what you think of Vox Markets on Good Money Guide: https://goodmoneyguide.com/review/vox-markets/ In this week’s smallcap investing show, rock star UK investor Paul Scott & I discussed our latest thoughts on the following:00:00 M&A boom and catalyst for smallcap re-rating04:45 ITV08:05 Kingfisher12:35 Auction Technology16:40 Paul’s buys this week18:50 Pets At Home & CVS Group23:05 Water Intelligence28:30 Beeks Financial30:55 Shearwater32:30 B&M Euro Value34:25 Macfarlane36:30 Essensys41:40 Supreme44:05 James Latham47:05 Spire Healthcare49:55 Evoke51:50 Anpario53:40 Gulf Marine Services54:55 Marks Electrical57:20 Getech57:50 Avingtrans59:50 Alpha Group International61:45 GlaxoPlus, if anyone or any company would like to sponsor this fund manager series (re naming rights), then please feel free to contact me here or via my email paulhill@pmhcapital.com.Published by Vox Markets


